Search Results

You are looking at 31 - 40 of 473 items for :

  • Refine by Access: All x
Clear All
Full access

Javaughn Corey R. Gray, Jongho Kim, Michael Digianvittorio, Nancy K. Feeley, Paul J. Scheel, Stanley S. Siegelman, Elliot K. Fishman, and Steven P. Rowe

/MEK-targeted inhibitors. 2 , 11 In a recent study of patients with ECD neurologic involvement, a combination of anatomic MRI and metabolic imaging with FDG-PET showed a high rate of objective response to targeted therapies such as vemurafenib. 12 This report presents a

Full access

Heather H. Cheng, Alexandra O. Sokolova, Edward M. Schaeffer, Eric J. Small, and Celestia S. Higano

rectal examination and prostate MRI (NCT03805919). If clinical trial participation is not available, annual PSA measurement for carriers of high-risk mutations should begin at age 40 years ( Figure 2 ). Men with PSA levels greater than the median age

Full access

Raymond Elsoueidi, Jessica Craig, Hesham Mourad, and Elie M. Richa

/L), a creatinine level of 1.9 mg/dL (range, 0.6-1.3 mg/dL), and a glomerular filtration rate (GFR) of 38 mL/min. Imaging studies, including magnetic resonance cholangiopancreatography and MRI of the liver, revealed a perihilar liver mass measuring 48.6 x

Full access

Ahmed Abdalla, Amr Aref, Amer Alame, Mohamad Barawi, Danny Ma, and Zyad Kafri

received conventional CRT with 5FU or capecitabine. All patients got MRI and endorectal ultrasound (ERUS) at baseline, after completing FOLFOX 3-months regimen and after finishing conventional CRT. Patients underwent either full-thickness local excision or

Full access

Stephanie A. Morris, Dorothy Farrell, and Piotr Grodzinski

, targeted nanoparticles can provide molecular imaging functionality through site- or activity-specific localization. Iron oxide nanoparticles provide a sensitive, low-toxicity alternative to standard MRI contrast agents, such as injected gadolinium. 39

Full access

Michelle L. McDonald and J. Kellogg Parsons

least one prior negative biopsy. 51 , 55 MRI Increasing interest is being shown in the role of multiparametric MRI in prostate cancer diagnosis. Recent evidence suggests a benefit of MRI-targeted prostate biopsy compared with standard transrectal

Full access

Cameron Czech, Ashley Chen, Katherine P. Morgan, Carlos Zamora, Sherif El-Refai, Norleena Poynter, and Simon Khagi

no significant past medical history presented with sudden onset of severe right-sided headache and emesis. MRI revealed 2 rim-enhancing lesions in the right temporal lobe. The patient underwent a gross total resection of the lesions, with surgical

Full access

Eric T. Wong and Steven Brem

tracking . J Mag Reson Imaging 2005 ; 22 : 710 – 717 . 45. Wong ET Jackson EF Hess KR . Correlation between dynamic MRI and outcome in patients with malignant gliomas . Neurology 1998 ; 50 : 777 – 781 . 46. Roberts HC Roberts

Full access

Chongkai Wang and Marwan Fakih

CA19-9 tumor marker response during treatment. (B) CT image from PET/CT scan before trastuzumab + lapatinib (red arrow: liver lesion, 2.4 × 1.4 cm). (C) MRI scan after 8 cycles of trastuzumab + lapatinib (red arrow: the same lesion, 0.7 × 0.9 cm

Full access

Agda Karina Eterovic, Ossama M. Maher, Joya Chandra, Ken Chen, Jason Huse, and Wafik Zaky

at the anterior mediastinum, liver, bone marrow, skull, and third lumber vertebra. Brain MRI revealed disease in the right orbital fossa extending to the middle cranial fossa, with no intracranial or cerebellar disease. The patient underwent fine